Relay Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $677 | $7,679 | $0 |
Gross Profit | -748 | 677 | 7,679 | -7,244 |
EBITDA | -73,401 | -75,845 | -83,661 | -83,645 |
EBIT | -74,149 | -76,847 | -84,869 | -84,979 |
Net Income | -74,149 | -70,375 | -77,065 | -76,004 |
Net Change In Cash | 0 | 677 | 7,679 | 0 |
Free Cash Flow | -62,118 | -55,287 | -73,594 | -57,868 |
Cash | 91,564 | 113,941 | 93,542 | 124,287 |
Basic Shares | 172,389 | 171,264 | 169,233 | 167,337 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,007 | $25,546 | $1,381 | $3,029 |
Gross Profit | 10,007 | 25,546 | 1,381 | 3,029 |
EBITDA | -380,210 | -374,153 | -306,822 | -223,082 |
EBIT | -385,674 | -379,422 | -310,952 | -227,007 |
Net Income | -337,708 | -341,973 | -290,509 | -363,872 |
Net Change In Cash | 10,007 | 25,546 | 1,381 | 3,029 |
Cost of Revenue | -128,325 | -165,827 | ||
Free Cash Flow | -251,125 | -304,442 | -238,552 | -77,877 |
Cash | 124,287 | 143,736 | 998,917 | 280,119 |
Basic Shares | 142,867 | 122,576 | 112,233 | 95,136 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.43 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.45 |
2024-12-31 | -$0.45 |
